gamma-Aminobutyric Acid-ergic Agonist class drugs

9 results
  • baclofen

    (Baclofen)
    Advagen Pharma Limited
    Baclofen injection is indicated for managing severe spasticity in patients aged 4 and older. It is used after a trial dose confirms response, primarily for spinal cord-related spasticity in those unresponsive to oral treatment or suffering severe side effects. Long-term use requires an implantable pump.
  • baclofen

    (Baclofen)
    ANI Pharmaceuticals, Inc.
    Baclofen oral suspension is indicated for treating spasticity due to multiple sclerosis, including relief from flexor spasms, pain, clonus, and muscular rigidity. It may also benefit patients with spinal cord injuries or diseases, but is not indicated for skeletal muscle spasms from rheumatic disorders.
  • baclofen

    (Baclofen)
    Upsher-Smith Laboratories, LLC
    Baclofen tablets are indicated for alleviating spasticity symptoms from multiple sclerosis, including flexor spasms, pain, clonus, and rigidity. They may benefit patients with spinal cord injuries. However, they are not recommended for muscle spasms due to rheumatic disorders or for stroke, cerebral palsy, and Parkinson's disease.
  • baclofen

    (BACLOFEN)
    SOLA Pharmaceuticals, LLC
    Baclofen tablets, USP are indicated for alleviating spasticity signs and symptoms from multiple sclerosis, including flexor spasms, pain, and rigidity. They may benefit patients with spinal cord injuries but are not recommended for rheumatic disorders, stroke, cerebral palsy, or Parkinson's disease due to unestablished efficacy.
  • baclofen

    (baclofen)
    Wilshire Pharmaceuticals, Inc.
    Baclofen is indicated for treating spasticity due to multiple sclerosis, relieving flexor spasms, pain, clonus, and muscular rigidity. It may also benefit patients with spinal cord injuries and diseases, but is not indicated for skeletal muscle spasms from rheumatic disorders.
  • baclofen

    (Baclofen)
    Palmetto Pharmaceuticals Inc.
    Baclofen oral solution is indicated for treating spasticity from multiple sclerosis, offering relief from flexor spasms, pain, clonus, and muscular rigidity. It may also benefit patients with spinal cord injuries and diseases, but is not for skeletal muscle spasms due to rheumatic disorders.
  • baclofen

    (BACLOFEN)
    Advagen Pharma Limited
    Baclofen tablets, USP are indicated for alleviating spasticity symptoms from multiple sclerosis, including flexor spasms, pain, clonus, and muscle rigidity. They may also be useful for spinal cord injuries and diseases. Baclofen is not recommended for muscle spasms from rheumatic disorders or conditions like stroke and Parkinson's disease.
  • fleqsuvy

    (baclofen)
    Azurity Pharmaceuticals, Inc.
    FLEQSUVY is indicated for treating spasticity due to multiple sclerosis, relieving flexor spasms, pain, clonus, and muscular rigidity. It may also benefit patients with spinal cord injuries or diseases, but is not intended for skeletal muscle spasms from rheumatic disorders.
  • gablofen

    (Baclofen Injection)
    Piramal Critical Care Inc
    GABLOFEN is indicated for managing severe spasticity in adult and pediatric patients aged 4 years and older. It is used for chronic infusion via an implantable pump in patients unresponsive to oral baclofen or experiencing intolerable side effects, with specific guidelines for spinal cord and traumatic brain injury cases.